Goserelin is a drug that has been designed to mimic the actions of GnRH, the hormone released from the hypothalamus gland in the brain. The hypothalamus uses GnRH to send messages to the pituitary gland in the brain, which then sends messages to the ovaries in females, and the testicles in males, telling them to produce the sex hormones estrogen (females) and testosterone (males). Goserelin is used to treat medical problems including prostate cancer, breast cancer (if it develops before or around the time of menopause), and endometriosis (a painful condition caused by growth of extra tissue inside or outside the uterus). It is also used to help thin the lining of the uterus before surgery on the uterus. Goserelin helps prostate cancer by causing a reduction in the amount of testosterone in the blood. It helps breast cancer, endometriosis and causes thinning of the lining of the uterus by reducing the amount of estrogen in the blood.



BCN Peptides manufactures in bulk under cGMP conditions LHRH (Gonadorelin) itself and a number of analogue agonists: